U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863791) titled 'Effect of Omega 3 Fatty Acids on Heart and Liver in Beta Thalassemia Patients' on Sept. 20.
Brief Summary: the aim of this interventional study to show the effect of taking omega 3 for about 6 months for patients beta thalassemia major maintained on standard of care and receiving the iron chelator deferasirox on liver, cardiac functions and transfusion index the patients randomly distributed to two groups group A receiving the omega 3 in dose 1gram pr day(50 patients) group b not receiving the drug
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Thalassemia Majors (Beta-Thalassemia Major)
Intervention:
DRUG: Ome...